La Peyronie's Disease (Ipp) and Extracorporeal Shock Waves Therapy (Eswt)

A Critical assessment of extracorporeal shock-wave therapy for Peyronie’s disease

“…A general subjective improvement was reported by 65% and 52% of the patients in the ESWT and in the control group, respectively. In this study, a complete disappearance of the plaque was found in 10% of the patients, comparable with the 9.1% rate reported by Gianneo et al [19], whereas in a very small group of patients treated with ESWT and previous unsuccessful oral therapy, plaques disappeared in 25% of the cases [24]. Interestingly, plaque disappearance was reported also in patients who did not receive any specific therapy for Peyronie's disease [28].…”

The management of Peyronie's disease

“…Because there are no large prospective randomized trials the use of different lithotripters, delivering variable amounts of energy, and the lack of objective treatment variables, any comparison of the results is difficult [55] (Table 2[56–61]). A recent prospective trial using a Siemens lithotripter reported a 91% reduction in penile pain and a 54% improvement in angulation, with a mean reduction of 31%[62].…”

Chapter 10

“…Riedl et al, 23 upon iontophoresis and verapamil, reported pain resolution in 96% of patients, whereas the plaque size was reduced in 53% and penile curvature was reduced in 37%. Montorsi et al 24 used the same methodology, however combining verapamil and dexamethasone, and the plaques dissolved in 90%, whereas penile curvature was reduced in 88% of patients.…”